The Invisible Wound: Silent Focal Breach of Skin Integrity that Cascades into Systemic Dysfunction and Chronic Morbidity

Skin failure, the proposition that compromised integumentary function can precipitate systemic decline, traces its intellectual lineage to the 19th century. Florence Nightingale framed bedsores (now pressure injuries) as preventable failures of care, a moral and clinical stance that ultimately shaped policy, including the 1987 Nursing Home Reform Act. In stark counterpoint, Jean-Martin Charcot’s decubitus ominosus cast certain ulcers as ominous, trophic harbingers of death in progressive neurological illness, an early recognition that breakdown can be unavoidable amid physiological exhaustion. This dialectic, preventable versus inexorable, persisted until late 20th-century demographics (aging, multimorbidity) forced a reckoning.^1,2 Concepts such as the Kennedy Terminal Ulcer (1989) and Skin Changes at Life’s End (SCALE, 2009) reframed integumentary decline as an end-organ failure phenomenon, akin to renal or hepatic collapse. ³ Today, skin failure spans a spectrum: an “inside-out” phenotype linked to systemic hypoperfusion and multiorgan dysfunction syndrome—mirroring classical organ failures—and an “outside-in” phenotype in which burns or toxic epidermal necrolysis breach the barrier and trigger infection, fluid derangements, and thermodysregulation in a self-reinforcing spiral.^4–6

OPEN IN VIEWER

Chandan K. Sen

SKIN BARRIER FAILURE OF THE “CLOSED” WOUND

At the heart of this evolution is impaired barrier function at the healing wound site—a signature of wound repair gone awry under the weight of complications—where healing is clinically determined but barrier function at the site of wound closure remains broken. Our work connects the historical arc to quantifiable physiology by proposing the concept of “invisible wounds”^7,8: wound sites that appear closed yet are deficient in barrier function and therefore remain functionally open. In 2014, we showed that mixed-species biofilms in chronic wounds disrupt epidermal barrier without visibly delaying closure—captured by elevated transepidermal water loss (TEWL)—thus establishing that apparent healing can mask profound functional deficits. ⁹ We validated this in a swine model of biofilm-infected burns: wounds that re-epithelialized yet maintained persistently high TEWL due to incomplete restoration of barrier function—structurally closed but functionally open. ⁷ These findings question current Food and Drug Administration (FDA) wound-closure endpoints—complete reepithelialization without exudate for 2 weeks—and argue for a revised endpoint seeking restoration of barrier function to support the clinical decision of wound closure. ¹⁰

TRANSLATIONAL MOMENTUM: TEWL AS A PROGNOSTIC ENDPOINT

Pilot clinical studies on wound patients demonstrated that elevated postclosure TEWL (>24.1 g/m²/h) predicts chronic wound recurrence across etiologies (area under the curve 0.967; odds ratio [OR] 1.34), independent of infection but associated with diabetes. ¹¹ We hypothesized that such postclosure TEWL signals deficient functional closure, an invisible wound, thereby directly disputing FDA-style wound closure endpoints and urging adoption of barrier restoration criteria to reduce recurrence risk. ¹⁰ The landmark 2025 NIDDK Diabetic Foot Consortium TEWL Study, a multicenter trial of 418 patients, substantially reinforced this framework: high central TEWL (>30.05 g/m²/h) was associated with 35% diabetic foot ulcer (DFU) recurrence versus 17% in low-TEWL wounds (OR 2.66, hazard ratio 2.43). ¹² Those wounds that close per FDA definition but fail to restore barrier function at the wound site are likely to recur. A companion analysis established TEWL as a marker of compromised functional closure ⁸ in DFUs, showing that baseline high TEWL forecast failure to sustain healing. ¹³ Our 2026 clinical review synthesized these findings and positioned TEWL measurement as an objective endpoint for functional wound healing—directly bridging barrier deficits with the broader spectrum of skin failure. ¹⁰

EVERYDAY INVISIBLE WOUNDS

Invisible wounds also arise from mundane insults such as sunburn. Acute overexposure to UV, chiefly UVB (290–320 nm), perturbs the stratum corneum lipid matrix (ceramides, cholesterol, and free fatty acids), elevates TEWL, and weakens mechanical integrity, producing a subclinical breach with increased permeability but no frank structural ulceration.^14–16 This may be viewed as focal skin failure: an external cue that silently compromises the barrier, opening the door to inflammation and pathogen ingress. Several cosmetic ingredients have been identified as potential disruptors of human skin barrier function altering lipid organization in the stratum corneum or exacerbating irritation. These effects are commonly studied in the context of cleansers, moisturizers, and other topical products.^17–20 Traditional soaps, often alkaline, inevitably destroy the skin barrier through repeated use by interacting with proteins and lipids, increasing susceptibility to irritants. High pH cleansers (e.g., pH 10) can swell the stratum corneum and alter lipid rigidity even without surfactants, exacerbating damage.^18,21 In healthy skin, these invisible wounds are expected to be transient as they would physiologically heal restoring barrier function within minutes, hours, or days. In those suffering from relevant underlying complications, for example, age-related disorders or diabetes, these everyday invisible wounds may gain chronicity and pose significant threats to systemic health as discussed below.

WHEN THE BARRIER FAILS: CLINICAL CONSEQUENCES AND CARE PATHWAYS

Barrier collapse invites infection, fluid imbalance, and thermodysregulation, sometimes necessitating dermatologic ICUs for severe cutaneous failure and integrated supportive/palliative care frameworks.^22–24 A focal barrier defect compromises the skin’s sentinel role against allergens, pathogens, and moisture loss, creating a vicious cycle where local fragility escalates into broader physiological instability, demanding strategies that restore the barrier and modulate immunity in tandem.

MOLECULAR ARCHITECTURE UNDER SIEGE

Barrier failure begins at the molecular level. Thermal or ischemic insults in burns and chronic wounds disrupt intercellular lipids (ceramides, cholesterol, and free fatty acids), dismantling lamellar membranes and elevating TEWL, with resulting xerosis.^25–28 Structural proteins within the cornified envelope are deranged: in ex vivo damage models mimicking burns/abrasions, loricrin expression can plummet by up to 90%, while involucrin surges, a compensatory but flawed repair program. Antimicrobial peptides decline, enabling microbial ingress, while matrix metalloproteinases hyperactivate, accelerating extracellular matrix (ECM) degradation.

Aging overlays a senescence-driven reprogramming: altered lipid composition, reduced natural moisturizing factors, and systemic mitochondrial dysfunction amplify dryness and fragility.^29–33 Environmental accelerants, oxidative stress and pollutants, further destabilize lipid–protein matrices, undermining reductionist models and emphasizing context-specific molecular entropy.^34–36

CELLULAR FALLOUT: HYPERACTIVE REPAIR, SENESCENCE, BIOFILMS, AND A SELF-PERPETUATING LOOP

At the cellular scale, the epidermis of barrier-function–deficient skin becomes a site of relentless, disordered remodeling. Keratinocytes hyperproliferate yet mis-differentiate in burn injury. Cytokine surges compromise tight junctions and desmosomes, delaying repair and elevating TEWL.^37–39 Apoptosis escalates through protease-mediated pathways, while senescent fibroblasts lose proliferative vigor and secrete bioactive mediators that drive mitochondrial dysfunction and ECM fragmentation, thinning the stratum corneum and decreasing elasticity.^40–43

Immune sentinels, dendritic cells and macrophages, mobilize to barrier breaches, releasing interleukins that fuel innate overdrive in infected chronic wounds.^9,44–46 Bacterial biofilms magnify epithelial stress and perpetuate chronicity.^47–49 The result is reciprocity in pathology: barrier compromise → immune infiltration → further barrier dismantling—the epidermis both instigator and casualty.

BEYOND THE SKIN: SYSTEMIC REVERBERATIONS AND ORGAN RISK

Skin barrier erosion is not parochial. In extensive burns, capillary leak and fluid extravasation precipitate hypovolemic shock and sepsis, with microbial and fungal translocation (e.g., Candida) threatening systemic collapse.^50,51 In diabetic ulcers, persistent TEWL and recurrent ingress of pathogens sustain infection, delay closure, and heighten amputation risk.

Aging-related thinning of the skin compounds susceptibility to infection, dehydration, and impaired thermoregulation.^30,52–55 Models quantifying permeability spikes postdamage reveal the double-edged sword of enhanced transcutaneous absorption, useful for drugs yet hazardous for toxins, underscoring the need to restore barrier function of the largest organ of the body.^37,56–62

FROM “OUTSIDE-IN” TO AIRWAY DISEASE: THE CUTANEOUS GATEWAY TO ATOPY

Compromised barrier function creates microscopic portals for allergens and microbes to traverse outside-in, eliciting Th2-skewed responses (elevated interleukin [IL]-4, IL-13) and sensitization that propagates through lymphatic or hematogenous routes to the lungs—fueling asthma and allergic rhinitis.^60,63–65 Strikingly, infants with early skin barrier dysfunction (elevated TEWL) can be identified with up to 100% sensitivity for progression from atopic dermatitis to respiratory allergies, arguing that the skin is a true sentinel organ whose breach triggers cascading systemic risk.^66–69

WARFIGHTER “INVISIBLE WOUNDS”: SUBCLINICAL BARRIER INJURY IN COMBAT

In combat trauma, invisible wounds are expected to be common and consequential. Blast overpressure, thermal exposures, and chemical insults can subtly disrupt the “bricks-and-mortar” architecture (corneocytes and intercellular lipids), elevating TEWL and permeability without overt hemorrhagic lacerations.^70–72 Primary blast waves induce barotrauma, microvascular injury, and oxidative stress that leave the skin barrier functionally open and infection-prone despite the deceptive intact surface appearance. Nonpenetrating burns from incendiary or fuel-air devices may initially appear superficial yet evolve into chronic inflammation, fibrosis, sepsis, or multiorgan dysfunction. Operational consequences are profound: median hospital stays exceed 20 days for moderate combat burns, with return-to-duty rates ranging from ≈85% for minor burns to <35% when severe hand injuries are involved—often necessitating evacuation and multidisciplinary rehabilitation.^73–75 These realities make a compelling case for advanced field diagnostics (e.g., smart TEWL monitoring) and barrier-centric trauma curricula to minimize downtime and bolster readiness.

AMPUTEE RESIDUAL LIMBS: FRICTION, SHEAR, AND THE “HIDDEN” BARRIER INJURY

Most lower extremity amputees experience skin breakdown, abrasions, or infections at the stump, aggravated by prosthetic friction and shear.^76–79 These invisible wounds ⁸⁰ complicate prosthetic fitting, prolong rehabilitation, and can escalate to osteomyelitis or sepsis, prompting revision surgeries and undermining reintegration. Emerging technologies, elevated vacuum suspension systems, help preserve perfusion and barrier function; randomized trials document reduced TEWL and attenuated reactive hyperemia with chronic use, arguing for proactive barrier-focused protocols in amputee care.^80–83

CONCLUSION: A CONTINUUM, NOT A VERDICT—OPERATIONALIZING TEWL FOR PRECISION HEALTH

The current state of evidence urges a shift from the avoidability versus inevitability debate to an evidence-based continuum of skin failure, where invisible wounds embody subclinical barrier erosion—a two-faced modern echo of Charcot’s omen. By operationalizing TEWL thresholds as predictors of wound recurrence and vulnerability, this framework supplies the empirical rigor needed to bridge etiologic silos and refine diagnostics.^10–13

The full clinical impact of this novel paradigm cannot be realized without robust, standardized, and field-ready technologies capable of rigorously measuring TEWL at the point of care. Current devices—variable in precision, calibration, usability, and environment sensitivity—limit widespread adoption and constrain the integration of TEWL into routine diagnostics. To detect and manage invisible wounds before they progress to overt failure, we urgently need next-generation TEWL platforms that are rigorously validated, clinically interoperable, portable, and resistant to environmental confounders. Such tools should empower frontline clinicians, wound-care teams, and even patients to capture barrier dysfunction in real time, guiding early intervention and verifying the achievement of functional, not merely structural, closure.

The path forward is precision intervention: therapies that restore barrier architecture while tuning immune tone, biofilm-aware strategies, and AI-enabled prognostics to identify functional nonclosure early. In an aging, multimorbid world, these reframing charts a humane, quantifiable trajectory for care ensuring that when the skin looks healed, it is truly restored in function.

ACKNOWLEDGMENTS AND FUNDING SOURCES

None declared.

AUTHOR DISCLOSURE AND GHOSTWRITING

There are no competing financial interests. The contents of this article were expressly written by the authors listed. No ghostwriters were used to write this article.